Drug
Rindopepimut With GM Csf
Rindopepimut With GM Csf: highest development phase Phase 3, developed by Celldex Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Celldex Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Rindopepimut (CDX-110) with GM-CSF NCT01480479 | Phase 3 | Glioblastoma |
Latest
No recent events.
Follow Rindopepimut With GM Csf on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.